NCT07243041 Code Status Discussions in Muslim ICU Patients: Insights Into Physician-Family Communication
| NCT ID | NCT07243041 |
| Status | Recruiting |
| Phase | — |
| Sponsor | King Faisal Specialist Hospital & Research Center |
| Condition | End of Life Care |
| Study Type | OBSERVATIONAL |
| Enrollment | 320 participants |
| Start Date | 2025-11-01 |
| Primary Completion | 2027-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 320 participants in total. It began in 2025-11-01 with a primary completion date of 2027-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This observational study aims to explore the real-time experiences, perceptions, and challenges faced by intensive care unit (ICU) physicians during goals-of-care discussions-specifically Do Not Attempt Resuscitation (DNAR) and end-of-life decision-making conversations-with families of critically ill patients in a Muslim-majority healthcare setting. The study seeks to identify factors that influence whether a DNAR decision is reached after physician-family discussions, and how physician experience, family dynamics, religious perspectives, and institutional support affect communication outcomes and care transitions. Participants will include ICU physicians (residents, fellows, and consultants) who routinely conduct DNAR discussions as part of clinical care. After each discussion, physicians will complete a brief structured questionnaire about their perceptions of the interaction, family emotions, and decision outcomes. These responses will be anonymously linked to limited, de-identified patient-level data (e.g., diagnosis, ICU course, and outcome) extracted retrospectively from the electronic medical record. No patients or family members will be contacted directly. Data collection will occur prospectively over two years at King Faisal Specialist Hospital \& Research Centre-Jeddah. Findings from this study are expected to provide culturally grounded insights that inform physician training, enhance family-centered communication, and guide policy development for DNAR and end-of-life discussions in Muslim-majority intensive care units.
Eligibility Criteria
Inclusion Criteria: * ICU physicians (residents, fellows, assistant consultants, or consultants) involved in direct patient care * ICU physicians who conduct code status or Do Not Attempt Resuscitation (DNAR) discussions with patients' families during ICU admission * Willingness of ICU physicians to participate voluntarily by completing a post-goals-of-care discussion questionnaire * Adult patients (≥18 years) admitted to the ICU during the study period for whom a code status discussion occurred Exclusion Criteria: * ICU physicians who decline participation * Code status discussions involving patients younger than 18 years of age * Discussions in which the physician was not directly involved
Contact & Investigator
Imran Khalid
PRINCIPAL INVESTIGATOR
King Faisal Specialist Hospital & Research Center
Frequently Asked Questions
Who can join the NCT07243041 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying End of Life Care. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07243041 currently recruiting?
Yes, NCT07243041 is actively recruiting participants. Contact the research team at ikhalid97@kfshrc.edu.sa for enrollment information.
Where is the NCT07243041 trial being conducted?
This trial is being conducted at Jeddah, Saudi Arabia.
Who is sponsoring the NCT07243041 clinical trial?
NCT07243041 is sponsored by King Faisal Specialist Hospital & Research Center. The principal investigator is Imran Khalid at King Faisal Specialist Hospital & Research Center. The trial plans to enroll 320 participants.